Clinical Trial Update: Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the immunogenicity of a birth dose of the hepatitis B vaccine conducted in the Democratic Republic of the Congo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED